Green Tea Peptide Therapeutics: AesturaRecent Research Landscape
Green tea peptides exhibit low bioavailability and rapid metabolic clearance, requiring specialized formulation to target muscle recovery and metabolic health.
What technical problems is Aestura addressing in Green Tea Peptide Therapeutics?
Systemic Burnout and Immunosenescence
(17)evidences
Ginseng berry polysaccharides and specific ginsenosides are required to mitigate macrophage inactivity and cytokine deficiency during physical exhaustion.
Sarcopenia and Metabolic Fatigue
(22)evidences
Muscle tissue degradation and metabolic fatigue require specific fermented green tea peptide fractions to prevent protein loss and cellular exhaustion.
Lipogenesis and Hepatic Dysregulation
(17)evidences
Excessive fat accumulation and liver oxidative stress occur when epigallocatechin gallate and isoquercetin ratios are not optimized for blood sugar regulation.